Page 18 - ASYMPTOMATIC COVID-19 QUARANTINE DIGITAL SOLUTION: A PROOF-OF-CONCEPT STUDY (NMRR-20-2761-57684)

ASYMPTOMATIC COVID-19 QUARANTINE DIGITAL SOLUTION: A PROOF-OF-CONCEPT
STUDY
18

The CODIQ-My mobile application was downloaded in candidate patients’ mobile

phones using APK (Android Application Package). Patients were then required to
register themselves to the system, where their demographic information obtained and

were trained on the use of the solution (both biosensor and mobile application). Each
patient was required to login through the mobile application two times a day for three

days consecutively, where they will be required to verify identification through facial

recognition technology. This was followed by measurement of vital signs either
through placement of the biosensor on the forehead/index finger, or on chest/finger,

or continuous placement on the wrist depending on the device used. Subsequently,
these patients would fill in a short survey on their experienced symptoms.

Data acquired were then analysed for these purposes:
1. to assess the feasibility of the biosensors in measuring the vital signs.

2. to assess the functionality of the system to demonstrate alerts on patients' risk
of deterioration.

Descriptive analysis including frequencies and percentages will be used for statistical

analysis on utilization and response of the solution. Every single successful check-in

attempt that was recorded into the system was analysed as one data point. Only the
data from patients who successfully enrolled into the system was used for the analysis

purposes. Data acquisition complied with the Personal Data Protection Act 2010. The
collected data was stored in the National Institutes of Health (NIH) Data Centre, which

abides to the data security regulations by MAMPU.

TECHNICAL REPORT

DIGITAL HEALTH RESEARCH AND INNOVATION

INSTITUTE FOR CLINICAL RESEARCH
NATIONAL INSTITUTES OF HEALTH